New study published in the Jan.

Aspirin therapy: Study raises safety issues Many people take an aspirin a full day to prevent heart attacks and strokes vérifier les informations . But a major, new study published in the Jan. 9 online edition of the Archives of Internal Medicine says that may not be the proper therapy for everyone, and may do more damage than good for some people. The research discovered that aspirin can trim heart attacks by 10 %, but raise the threat of inner bleeding by 30 %. Dr. Jon LaPook talked about the risks versus the advantages of aspirin therapy, and also explained who should be taking it and who doesn’t really need it on ‘CBS This Morning.’ He also discussed a second study published Mon in the Archives of Internal Medication that says statins – – cholesterol-lowering medicines that are one of the most widely prescribed medicines – – have a side-effect that may increase some people’s likelihood of developing Type 2 diabetes.

Aspirin may modestly reduce cancer risk A daily dose of adult-strength aspirin may reduce cancer risk in populations with high rates of colorectal modestly, prostate, and breasts cancer if taken for at least five years. The Women’s Health Study trial recently reported that long-term usage of low-dose aspirin does not reduce a woman’s cancers risk, but it did not examine whether high doses of aspirin have an effect on cancer risk. Eric Jacobs, Ph.D., of the American Cancer Society in Atlanta, and co-workers appeared for associations between long-term daily aspirin use and malignancy incidence in a group of nearly 70,000 males and 76,000 ladies. Aspirin use was determined by a questionnaire. Related StoriesCornell biomedical engineers develop 'super organic killer cells' to destroy cancer cells in lymph nodesNew Haven Pharmaceuticals' DURLAZA medication delivers sustained antiplatelet control for full 24 hoursSausages With Antioxidants From Berries TO AVOID CancerDuring the 12 season follow-up, nearly 18, 000 men and women in the scholarly study were diagnosed with cancer.